Combined portal and hepatic vein embolisation in perihilar cholangiocarcinoma

Jens Smits,Steven Chau,Sinéad James,Remon Korenblik,Madita Tschögl,Pieter Arntz,Jan Bednarsch,Luis Abreu de Carvalho,Olivier Detry,Joris Erdmann,Thomas Gruenberger,Laurens Hermie,Ulf Neumann,Per Sandström,Robert Sutcliffe,Alban Denys,Emmanuel Melloul,Maxime Dewulf,Christiaan van der Leij,Ronald M van Dam,EuroLVD and DRAGON Trials Collaborative,Patrick Chevallier,Stephen Wigmore,Timothy Newhook,Jean-Nicolas Vauthey,Riccardo Memeo,Bobby Vm Dasari,Eva Braunwarth,Luca Aldrighetti,Laurens van Baardewijk,Louise Barbier,Christoph Binkert,Bergthor Björnsson,Esteban Cugat Andorrà,Bulent Arslan,Ivan Baclija,Marc Bemelmans,Clare Bent,Marieke T de Boer,Reinoud P H Bokkers,Diederick de Boo,David Breen,Stefan Breitenstein,Philipp Bruners,Alberta Cappelli,Ulrik Carling,Margarida Casellas I Robert,Benjamin Chan,Franceso De Cobelli,Charles Cha,Julian Choi,Michael Crawford,Daniel Croagh,Ronald van Dam,Fabrice Deprez,Rafael Díaz-Nieto,Alexandra Dili,Joris I Erdmann,Jaume Codina Font,Rob Davis,Martin Delle,Rukshan Fernando,Oliver Fisher,Suomi Fouraschen,Åsmund A Fretland,Yilian Fundora,Arantxa Gelabert,Laurent Gerard,Paul Gobardhan,Fernando Gómez,Felice Guiliante,Lukasz Filip Grochola,Dirk Grünhagen,Josep Guitart Giménez,Jeroen Hagendoorn,Jan Heil,Daniel Heise,Eric Herrero,Gebriel Hess,Mohammed Abu Hilal,Martin Hoffmann,Roberto Iezzi,Farshad Imani,Nakarin Inmutto,Sinead James,Francisco Javier Garcia Borobia,Elio Jovine,Jennifer Kalil,Peter Kingham,Otto Kollmar Clarunis,Jörg Kleeff,Santiago Lopez-Ben,Andrew Macdonald,Martijn Meijerink,Worakitti Lapisatepun,Wouter Leclercq,Richard Lindsay,Valerio Lucidi,David C Madoff,Guillaume Martel,Homoyon Mehrzad,Krishna Menon,Peter Metrakos,Sachin Modi,Adriaan Moelker,Nicola Montanari,Jaume Sampere Moragues,Jordi Navinés López,Julian Nguyen,Praveen Peddu,John Primrose,Steven Olde Damink,Xudong Qu,Dimitri A Raptis,Francesca Ratti,Stephen Ryan,Fourat Ridouani,Inne H M Borel Rinkes,Chris Rogan,Ulrich Ronellenfitsch,Matteo Serenari,Aysun Salik,Claudio Sallemi,Ernesto Santos Martin,Luis Sarría,Erik Schadde,Alejandro Serrablo,Utz Settmacher,Maarten Smits,Andreas Snitzbauer,Zahir Soonawalla,Ernesto Sparrelid,Elmar Spuentrup,Gregor Stavrou,Ilario Tancredi,Jordan C Tasse,Ulf Teichgräber,Venkatesha Udupa,David A Valenti,David Vass,Thomas Vogl,Xiaoying Wang,Steven White,Jean-François De Wispelaere,Walter Wohlgemuth,Dominic Yu,Ijsbrand Zijlstra

DOI: https://doi.org/10.1016/j.hpb.2024.07.407

2024-07-16

Abstract:Background: Major hepatectomy in perihilar cholangiocarcinoma (pCCA) patients with a small future liver remnant (FLR) risks posthepatectomy liver failure (PHLF). This study examines combined portal and hepatic vein embolisation (PVE/HVE) to increase preoperative FLR volume and potentially decrease PHLF rates. Methods: In this retrospective, multicentre, observational study, data was collected from centres affiliated with the DRAGON Trials Collaborative and the EuroLVD registry. The study included pCCA patients who underwent PVE/HVE between July 2016 and January 2023. Results: Following PVE/HVE, 28% of patients (9/32) experienced complications, with 22% (7/32) necessitating biliary interventions for cholangitis. The median degree of hypertrophy after a median of 16 days was 16% with a kinetic growth rate of 6.8% per week. 69% of patients (22/32) ultimately underwent surgical resection. Cholangitis after PVE/HVE was associated with unresectability. After resection, 55% of patients (12/22) experienced complications, of which 23% (5/22) were Clavien-Dindo grade III or higher. The 90-day mortality after resection was 0%. Conclusion: PVE/HVE quickly enhances the kinetic growth rate in pCCA patients. Cholangitis impairs chances on resection significantly. Resection after PVE/HVE is associated with low levels of 90-day mortality. The study highlights the potential of PVE/HVE in improving safety and outcomes in pCCA undergoing resection.